Literature DB >> 23973224

Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22.

Teresa Zelante1, Rossana G Iannitti, Cristina Cunha, Antonella De Luca, Gloria Giovannini, Giuseppe Pieraccini, Riccardo Zecchi, Carmen D'Angelo, Cristina Massi-Benedetti, Francesca Fallarino, Agostinho Carvalho, Paolo Puccetti, Luigina Romani.   

Abstract

Endogenous tryptophan (Trp) metabolites have an important role in mammalian gut immune homeostasis, yet the potential contribution of Trp metabolites from resident microbiota has never been addressed experimentally. Here, we describe a metabolic pathway whereby Trp metabolites from the microbiota balance mucosal reactivity in mice. Switching from sugar to Trp as an energy source (e.g., under conditions of unrestricted Trp availability), highly adaptive lactobacilli are expanded and produce an aryl hydrocarbon receptor (AhR) ligand-indole-3-aldehyde-that contributes to AhR-dependent Il22 transcription. The resulting IL-22-dependent balanced mucosal response allows for survival of mixed microbial communities yet provides colonization resistance to the fungus Candida albicans and mucosal protection from inflammation. Thus, the microbiota-AhR axis might represent an important strategy pursued by coevolutive commensalism for fine tuning host mucosal reactivity contingent on Trp catabolism.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23973224     DOI: 10.1016/j.immuni.2013.08.003

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  702 in total

1.  Lactobacillus reuteri induces gut intraepithelial CD4+CD8αα+ T cells.

Authors:  Luisa Cervantes-Barragan; Jiani N Chai; Ma Diarey Tianero; Blanda Di Luccia; Philip P Ahern; Joseph Merriman; Victor S Cortez; Michael G Caparon; Mohamed S Donia; Susan Gilfillan; Marina Cella; Jeffrey I Gordon; Chyi-Song Hsieh; Marco Colonna
Journal:  Science       Date:  2017-08-03       Impact factor: 47.728

Review 2.  Ah receptor ligands and their impacts on gut resilience: structure-activity effects.

Authors:  Stephen Safe; Arul Jayaraman; Robert S Chapkin
Journal:  Crit Rev Toxicol       Date:  2020-06-29       Impact factor: 5.635

Review 3.  Dysbiosis and the immune system.

Authors:  Maayan Levy; Aleksandra A Kolodziejczyk; Christoph A Thaiss; Eran Elinav
Journal:  Nat Rev Immunol       Date:  2017-03-06       Impact factor: 53.106

Review 4.  Regulation of inflammation by microbiota interactions with the host.

Authors:  J Magarian Blander; Randy S Longman; Iliyan D Iliev; Gregory F Sonnenberg; David Artis
Journal:  Nat Immunol       Date:  2017-07-19       Impact factor: 25.606

Review 5.  The microbiome and regulation of mucosal immunity.

Authors:  Andrew J McDermott; Gary B Huffnagle
Journal:  Immunology       Date:  2014-05       Impact factor: 7.397

Review 6.  Intestinal Lactobacillus in health and disease, a driver or just along for the ride?

Authors:  Dustin D Heeney; Mélanie G Gareau; Maria L Marco
Journal:  Curr Opin Biotechnol       Date:  2017-09-01       Impact factor: 9.740

Review 7.  Innate Lymphoid Cell Immunometabolism.

Authors:  Timothy E O'Sullivan; Joseph C Sun
Journal:  J Mol Biol       Date:  2017-09-01       Impact factor: 5.469

Review 8.  Learning from other diseases: protection and pathology in chronic fungal infections.

Authors:  Teresa Zelante; Giuseppe Pieraccini; Lucia Scaringi; Franco Aversa; Luigina Romani
Journal:  Semin Immunopathol       Date:  2015-09-17       Impact factor: 9.623

Review 9.  Recent trends and future directions for the medical treatment of ulcerative colitis.

Authors:  Makoto Naganuma; Shinta Mizuno; Kosaku Nanki; Shinya Sugimoto; Takanori Kanai
Journal:  Clin J Gastroenterol       Date:  2016-10-03

Review 10.  The interplay between the intestinal microbiota and the immune system.

Authors:  Yuk Man Kevin Lei; Lekha Nair; Maria-Luisa Alegre
Journal:  Clin Res Hepatol Gastroenterol       Date:  2014-11-11       Impact factor: 2.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.